메뉴 건너뛰기




Volumn 15, Issue 1, 2015, Pages

A retrospective analysis of breast cancer subtype based on ER/PR and HER2 status in Ghanaian patients at the Korle Bu Teaching Hospital, Ghana

Author keywords

Breast cancer; ER; HER2; PR; Subtype

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; PACLITAXEL; PROGESTERONE RECEPTOR;

EID: 84936070272     PISSN: None     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/s12907-015-0014-4     Document Type: Article
Times cited : (32)

References (42)
  • 1
    • 84936067779 scopus 로고    scopus 로고
    • WHO 2008
    • WHO 2008
  • 2
    • 34249033328 scopus 로고    scopus 로고
    • Breast Cancer Mortality Trends in the United States According to Estrogen Receptor Status and Age at Diagnosis
    • 17404367
    • Jatoi I, Chen BE, Anderson WF, Rosenberg PS. Breast Cancer Mortality Trends in the United States According to Estrogen Receptor Status and Age at Diagnosis. J Clin Oncol. 2007;25(13):1683-90.
    • (2007) J Clin Oncol , vol.25 , Issue.13 , pp. 1683-1690
    • Jatoi, I.1    Chen, B.E.2    Anderson, W.F.3    Rosenberg, P.S.4
  • 4
    • 12844270607 scopus 로고    scopus 로고
    • Breast Cancer in African American women
    • 15632248
    • Newman LA. Breast Cancer in African American women. Oncologist. 2005;10:1-14.
    • (2005) Oncologist , vol.10 , pp. 1-14
    • Newman, L.A.1
  • 6
    • 69249194944 scopus 로고    scopus 로고
    • Treatment of Breast Cancer in Accra: 5 year Survival
    • Baako BN, Badoe EA. Treatment of Breast Cancer in Accra: 5 year Survival. Ghana Med J. 2001;35:90-5.
    • (2001) Ghana Med J , vol.35 , pp. 90-95
    • Baako, B.N.1    Badoe, E.A.2
  • 7
    • 77953248475 scopus 로고    scopus 로고
    • Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10
    • 159 Cases from 12 Studies
    • Blows FM, Driver KE, Schmidt MK, Broeks A, van Leeuwen FE, et al. (2010) Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies. PLoS Med 7(5): e1000279. doi: 10.1371/journal.pmed.1000279
    • (2010) PLoS Med , vol.7 , Issue.5 , pp. e1000279
    • Blows, F.M.1    Driver, K.E.2    Schmidt, M.K.3    Broeks, A.4    Van Leeuwen, F.E.5
  • 10
    • 0035754641 scopus 로고    scopus 로고
    • Who should not receive adjuvant chemotherapy? International databases
    • 11773301
    • Bergh J, Holmquist M. Who should not receive adjuvant chemotherapy? International databases. J Natl Cancer Inst Monogr. 2001;30:103-8.
    • (2001) J Natl Cancer Inst Monogr , vol.30 , pp. 103-108
    • Bergh, J.1    Holmquist, M.2
  • 13
    • 70449185514 scopus 로고
    • Histological grading and prognosis in breast cancer; A study of 1409 cases of which 359 have been followed for 15 years
    • 1:STN:280:DyaG1c%2Fkt1Gmtg%3D%3D 2073885 13499785
    • Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957;11(3):359-77.
    • (1957) Br J Cancer , vol.11 , Issue.3 , pp. 359-377
    • Bloom, H.J.1    Richardson, W.W.2
  • 14
    • 84866455237 scopus 로고    scopus 로고
    • Breast cancer in Kumasi, Ghana
    • 1:STN:280:DC%2BC38nkt1WmtA%3D%3D 3353503 22605883
    • Ohene-Yeboah M, Adjei E. Breast cancer in Kumasi, Ghana. Ghana Med J. 2012;46(1):8-13.
    • (2012) Ghana Med J , vol.46 , Issue.1 , pp. 8-13
    • Ohene-Yeboah, M.1    Adjei, E.2
  • 15
    • 0034680102 scopus 로고    scopus 로고
    • Molecular portraits of human breast tumours
    • Perou CM, Sùrlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406.
    • Nature , vol.2000 , pp. 406
    • Perou Cm, S.1
  • 17
    • 4143150688 scopus 로고    scopus 로고
    • Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
    • 1:CAS:528:DC%2BD2cXmvFSlt7k%3D 15328174
    • Nielsen TO, Hsu FD, Jensen K, Cheng M, Karaca G, Hu Z, et al. Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma. Clin Cancer Res. 2004;10:5367-74.
    • (2004) Clin Cancer Res , vol.10 , pp. 5367-5374
    • Nielsen, T.O.1    Hsu, F.D.2    Jensen, K.3    Cheng, M.4    Karaca, G.5    Hu, Z.6
  • 19
    • 84865122721 scopus 로고    scopus 로고
    • Invasive breast carcinomas in Ghana: High frequency of high grade, basal-like histology and high EZH2 expression
    • 1:CAS:528:DC%2BC38XhtFOkurvM 3906643 22527102
    • Pang J, Toy KA, Griffith KA, Awuah B, Quayson S, Newman LA, et al. Invasive breast carcinomas in Ghana: high frequency of high grade, basal-like histology and high EZH2 expression. Breast Cancer Res Treat. 2012;135(1):59-66.
    • (2012) Breast Cancer Res Treat , vol.135 , Issue.1 , pp. 59-66
    • Pang, J.1    Toy, K.A.2    Griffith, K.A.3    Awuah, B.4    Quayson, S.5    Newman, L.A.6    Kleer, C.G.7
  • 21
    • 0036569877 scopus 로고    scopus 로고
    • The pathology of familial breast cancer: Predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2
    • 1:CAS:528:DC%2BD38XktVKrs7o%3D 11981002
    • Lakhani SR, Van De Vijver MJ, Jacquemier J, Anderson TJ, Osin PP, McGuffog L, et al. The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol. 2002;20(9):2310-8.
    • (2002) J Clin Oncol , vol.20 , Issue.9 , pp. 2310-2318
    • Lakhani, S.R.1    Van De Vijver, M.J.2    Jacquemier, J.3    Anderson, T.J.4    Osin, P.P.5    McGuffog, L.6    Easton, D.F.7
  • 27
    • 19344364880 scopus 로고    scopus 로고
    • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials
    • Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
    • Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687-717.
    • (2005) Lancet , vol.365 , Issue.9472 , pp. 1687-1717
  • 28
    • 60349102490 scopus 로고    scopus 로고
    • Treatment of established breast cancer in post-menopausal women: Role of aromatase inhibitors
    • 1:STN:280:DC%2BD1M7ms1OmtQ%3D%3D 19241985
    • Samphao S, Eremin JM, El-Sheemy M, Eremin O. Treatment of established breast cancer in post-menopausal women: role of aromatase inhibitors. Surgeon. 2009;7(1):42-55.
    • (2009) Surgeon , vol.7 , Issue.1 , pp. 42-55
    • Samphao, S.1    Eremin, J.M.2    El-Sheemy, M.3    Eremin, O.4
  • 30
    • 77953345188 scopus 로고    scopus 로고
    • Trastuzumab treatment in patients with breast cancer and metastatic CNS disease
    • 1:STN:280:DC%2BC3c3ptFOmtA%3D%3D 19717536
    • Pienkowski T, Zielinski CC. Trastuzumab treatment in patients with breast cancer and metastatic CNS disease. Ann Oncol. 2010;21(5):917-24.
    • (2010) Ann Oncol , vol.21 , Issue.5 , pp. 917-924
    • Pienkowski, T.1    Zielinski, C.C.2
  • 37
    • 79955876613 scopus 로고    scopus 로고
    • Mastectomy and contralateral prophylactic mastectomy rates: An institutional review
    • 21125335
    • Damle S, Teal CB, Lenert JJ, Marshall EC, Pan Q, McSwain AP. Mastectomy and contralateral prophylactic mastectomy rates: an institutional review. Ann Surg Oncol. 2011;18(5):1356-63.
    • (2011) Ann Surg Oncol , vol.18 , Issue.5 , pp. 1356-1363
    • Damle, S.1    Teal, C.B.2    Lenert, J.J.3    Marshall, E.C.4    Pan, Q.5    McSwain, A.P.6
  • 39
    • 84863717818 scopus 로고    scopus 로고
    • Increasing mastectomy rates among all age groups for early stage breast cancer: A 10-year study of surgical choice
    • 22607016
    • Dragun AE, Huang B, Tucker TC, Spanos WJ. Increasing mastectomy rates among all age groups for early stage breast cancer: a 10-year study of surgical choice. Breast J. 2012;18(4):318-25.
    • (2012) Breast J , vol.18 , Issue.4 , pp. 318-325
    • Dragun, A.E.1    Huang, B.2    Tucker, T.C.3    Spanos, W.J.4
  • 42
    • 79953051295 scopus 로고    scopus 로고
    • Why do breast cancer patients report late or abscond during treatment in Ghana? A pilot study
    • 1:STN:280:DC%2BC3c%2FotVSgsw%3D%3D 2810246 20126325
    • Clegg-Lamptey J, Dakubo J, Attobra YN. Why do breast cancer patients report late or abscond during treatment in ghana? A pilot study. Ghana Med J. 2009;43(3):127-31.
    • (2009) Ghana Med J , vol.43 , Issue.3 , pp. 127-131
    • Clegg-Lamptey, J.1    Dakubo, J.2    Attobra, Y.N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.